(PRWEB) September 14, 2012
Manufactured by Novartis, Tekturna is a high blood pressure (hypertension) medication taken by patients with, or who are at risk for, this problem. The U.S. Food and Drug Administration (FDA) first approved Tekturna in 2007, as a means to treat hypertension. However, due to lower-than-expected sales, Novartis looked to expand the use of Novartis to include treating type-2 diabetics with kidney problems. Novartis then conducted a study to see how effective this new use would be. Far from proving beneficial to patients and Novartis alike, the results of the study have added credibility to the claims on many Tekturna patients who have experience complications from using the drug.
The complications and side effects that have allegedly been linked to the use of Tekturna include the following:
Due to these complications, Novarits is now on the brink of legal action taken on behalf of patients who were injured by the use of Tekturna. No doubt the majority of claims against Novartis will pertain to the issue of whether they placed a drug on the market that was somehow defective. The drug’s defectiveness may be determined, among other things, by an improper design in the drug which caused these terrible side effects, and/or the manufacturer’s failure to warn patients and medical providers of the serious side effects associated with the use of Tekturna.
The attorneys at d’Oliveira & Associates urge any one who has suffered from the use of Tekturna to contact them immediately. They are working with some of the leading dangerous drug lawyers in the country who are handling these cases. They want to ensure that all potential Tekturna clients understand that there is absolutely no fee unless a settlement is reached, or an award is won.
For a free legal consultation, call 1-800-992-6878 or visit their website at Tekturna Lawsuit Lawyer